NORTON J. GREENBERGER, M.D.; RICHARD D. RUPPERT, M.D.; MANUEL TZAGOURNIS, M.D.
GREENBERGER NJ, RUPPERT RD, TZAGOURNIS M. Use of Medium Chain Triglycerides in Malabsorption. Ann Intern Med. 1967;66:727-734. doi: 10.7326/0003-4819-66-4-727
Download citation file:
Published: Ann Intern Med. 1967;66(4):727-734.
Recent clinical observations have indicated that triglycerides containing medium chain fatty acids may be useful in decreasing the steatorrhea associated with a variety of malabsorptive disorders. It has been demonstrated that medium chain triglycerides (MCT) are of value in treating patients with pancreatic insufficiency (1), extrahepatic biliary tract obstruction (2), postgastrectomy steatorrhea (3), a-beta-lipoproteinemia (4), intestinal lymphangiectasia (5), cystic fibrosis of the pancreas (6), and massive small-bowel resection (7). Although it has been well documented that therapy with MCT results in decreased steatorrhea, there is little evidence available correlating decreased steatorrhea with weight gain. Moreover, there is little information concerned
Learn more about subscription options.
Register Now for a free account.
Celiac Disease and Malabsorption, Gastroenterology/Hepatology.
Results provided by:
Copyright © 2017 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use
This PDF is available to Subscribers Only